(9501818), M. S. A., (9501821), H. A., (2029159), P. W., (360936), A. d. l. F., (3607649), M. X., (291722), N. R., & (291723), P. J. T. (2020). Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection.
Chicago Style (17th ed.) Citation(9501818), Maryam S. Al-Motawa, Hafsa Abbas (9501821), Patrick Wijten (2029159), Alberto de la Fuente (360936), Mingzhan Xue (3607649), Naila Rabbani (291722), and Paul J. Thornalley (291723). Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection. 2020.
MLA (9th ed.) Citation(9501818), Maryam S. Al-Motawa, et al. Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection. 2020.